MRTX - Mirati Therapeutics, Inc.
Close
58.7
-0.100 -0.170%
Share volume: 0
Last Updated: Mon 22 Jan 2024 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$58.80
-0.10
-0.17%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-04 | 2022-08-03 | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-06 | |
| Cash flow financing | 2.527 M | 1.392 M | 157.105 M | 5.920 M | 1.727 M | 3.843 M | 334.700 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -160.469 M | -143.492 M | -137.809 M | -128.800 M | -190.182 M | -131.400 M | -143.713 M | |
| Net income | -188.386 M | -176.445 M | -173.561 M | -202.475 M | -184.586 M | -176.913 M | -161.904 M | |
| Depreciation | 629.000 K | 693.000 K | 716.000 K | 891.000 K | 1.075 M | 1.107 M | 1.115 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 3.020 M | 3.849 M | 8.644 M | 20.156 M | |
| Changes in receivables | 4.846 M | 10.663 M | 9.092 M | 6.032 M | 7.735 M | 5.175 M | 5.478 M | |
| Investing Cashflow | 49.555 M | 103.006 M | 13.945 M | 59.297 M | 195.151 M | 15.532 M | -62.194 M | |
| Net Borrowings | -1.338 B | -1.192 B | -1.217 B | -1.100 B | -927.766 M | -805.098 M | -1.010 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.140 M | -1.661 M | -1.240 M | -810.000 K | -269.000 K | -722.000 K | -36.000 K | |
| Cash Change | 1.326 B | 1.181 B | 1.201 B | 1.084 B | 902.294 M | 779.434 M | 976.434 M |